In line with these results, Kaplan–Meier survival analysis based on CPTAC clinical data suggested that HCC patients with high protein expression of BCLAF1 had significantly shorter overall survival than HCC patients with low protein expression of BCLAF1 (Fig. 1r). Here, BCLAF1 is linked to hepatocellular carcinoma.